T1	Participants 76 120	therapy for Helicobacter pylori eradication.
T2	Participants 698 700	H.
T3	Participants 701 896	pylori-positive patients with gastric or duodenal ulcers or erosive gastritis, treated after failure of dual therapy (proton-pump-inhibitors or ranitidine plus amoxicillin) or for the first time.
T4	Participants 1294 1397	total of 71 patients were treated by quadruple therapy, and 42 patients were treated by triple therapy.
